Global® AP™ Total Shoulder Arthroplasty
A Multi-center Clinical Study of the Global® AP™ Shoulder in Total Shoulder Arthroplasty
1 other identifier
interventional
64
1 country
4
Brief Summary
This study will evaluate the clinical performance of DePuy Global® AP™ Shoulder prosthesis using the anchor pegged glenoid component and clinical and radiographic evaluations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2008
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2008
CompletedFirst Submitted
Initial submission to the registry
July 21, 2008
CompletedFirst Posted
Study publicly available on registry
July 22, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2013
CompletedMay 22, 2014
December 1, 2013
5.8 years
July 21, 2008
May 20, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Constant Shoulder Score
Pre-op, 6, 12, 24 months
Secondary Outcomes (4)
SF-12
Pre-op, 6,12, 24 months
Penn/ASES
Pre-Op, 6, 12, and 24 months
Radiographic Data
Pre-Op, 6 weeks, 6, 12, and 24 months
Quality of Life Survey
6 weeks
Study Arms (1)
Global® AP™ Shoulder
OTHERGlobal® AP™ Shoulder
Interventions
Total shoulder arthroplasty
Eligibility Criteria
You may not qualify if:
- Are under 18 years of age or over 70
- Diagnosis of AVN, Inflammatory Arthritis, Fracture or Malunion.
- Have a hemi-arthroplasty
- Have destruction of the proximal humerus that precludes rigid fixation of the humeral component
- Have arthritis with insufficient cuff tissue
- Have had a failed rotator cuff surgery
- Have loss of musculature, neuromuscular compromise or vascular deficiency in the affected limb rendering the procedure unjustified
- Have evidence of active infection
- Present with a condition of neuromuscular compromise of the shoulder (e.g., neuropathic joints or brachial plexus injury with a flail shoulder joint) - Have a known active metastatic or neoplastic disease
- Are unwilling or unable to comply with a rehabilitation program or would fail to return for the postoperative follow-up visits prescribed by the protocol
- Are skeletally immature.
- Have a known allergic reaction to implant metals, polyethylene or a tissue reaction to corrosion or wear products
- Have other conditions such as central nervous system disturbances, alcohol or drug addiction, etc. that may make effective evaluation of the joint replacement difficult or impossible
- Are currently participating in another clinical study
- Are taking \> 10mg/day corticosteroids (e.g. prednisone) excluding inhalers, within 3 months prior to surgery
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
The CORE Institute
Phoenix, Arizona, 85027, United States
Mission Hospitals Research Institute
Asheville, North Carolina, 28801, United States
Wellington Orthopaedics and Sports Medicine
Cincinnati, Ohio, 45230, United States
Rosenberg Cooley Metcalf Clinic
Park City, Utah, 84060, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Sam Himden, BA
DePuy Orthopaedics
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 21, 2008
First Posted
July 22, 2008
Study Start
January 1, 2008
Primary Completion
October 1, 2013
Study Completion
October 1, 2013
Last Updated
May 22, 2014
Record last verified: 2013-12